ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

National Cancer Act: Early Promises Were Overstated

May 15, 1998

Rising Obesity May Result In Higher Cancer Incidence

August 27, 2010

Letters to the Editor: Love on Mammography; Freireich, Holland On Bernard Fisher

April 15, 1994

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

Nutrition RFP Canceled, Job Added To Existing Contract

April 4, 1975

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995